Profile
Sherron Kell worked as a Senior Vice President of Clinical Development at Provention Bio, Inc. from 2019 to 2021.
Prior to this, Kell obtained a graduate degree from The University of Alabama at Birmingham and an MBA from The University of Alabama School of Medicine.
Former positions of Sherron Kell
Companies | Position | End |
---|---|---|
PROVENTION BIO, INC. | Corporate Officer/Principal | 2021-11-16 |
Training of Sherron Kell
The University of Alabama School of Medicine | Masters Business Admin |
The University of Alabama at Birmingham | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
Provention Bio, Inc.
Provention Bio, Inc. Pharmaceuticals: MajorHealth Technology Provention Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapeutics and solutions. Its products include PRV-031 for the interception of type 1 diabetes (T1D), PRV-015 for the treatment of gluten-free diet non-responding celiac disease, PRV-6527 for Crohn’s disease, PRV-3279 for the treatment of lupus, and PRV-101 for the prevention of acute coxsackie virus B (CVB), and the prevention of type 1 diabetes (T1D) onset. The company was founded by Francisco Leon and Ashleigh Palmer on October 4, 2016 and is headquartered in Red Bank, NJ. | Health Technology |
- Stock Market
- Insiders
- Sherron Kell